Brooklyn Park, Minn.-based 4C Medical Technologies has raised about $9 million in gross proceeds in a private placement of unsecured convertible promissory notes. The proceeds will be used to continue the development of the company's transcatheter technology for mitral regurgitation treatment.
Private placement pulls in $9M for 4C Medical Technologies
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.